DOI:10.2214/AJR.08.1537
AJR 2009; 193:W58-W63
© American Roentgen Ray Society
Invasive Micropapillary Carcinoma of the Breast: Mammographic, Sonographic, and MRI Features
Beatriz Adrada1,
Elsa Arribas1,
Michael Gilcrease2 and
Wei Tse Yang1
1 Department of Diagnostic Radiology, The University of Texas M. D. Anderson
Cancer Center, 1515 Holcombe Blvd., Unit 1350, Houston, TX 77030.
2 Department of Surgical Pathology, The University of Texas M. D. Anderson
Cancer Center, Houston, TX.
Received July 14, 2008;
accepted after revision January 9, 2009.
Presented at the 2008 annual meeting of the American Roentgen Ray Society,
Washington, DC.
Address correspondence to W. T. Yang
(wyang{at}mdanderson.org).
WEB This is a Web exclusive article.
Abstract
OBJECTIVE. The purpose of this study was to describe the clinical,
imaging, and histopathologic findings of invasive micropapillary carcinoma of
the breast.
CONCLUSION. The imaging characteristics of invasive micropapillary
carcinoma are highly suggestive of malignancy. The lesion is a high-density
irregular mass with indistinct margins associated with microcalcifications on
mammograms; a solid irregular hypoechoic mass with indistinct margins and
frequent axillary nodal involvement on sonograms; and a multifocal mass on MR
images. This tumor may necessitate aggressive management.
Keywords: breast carcinoma mammography micropapillary MRI neoplasm pathology prognosis sonography
Introduction
Invasive micropapillary carcinoma is a rare, clinically aggressive
variant of invasive ductal cancer that accounts for 0.7-3% of all cases of
breast cancer
[1-3].
It has only recently been recognized as a morphologically distinct entity.
This tumor is a unique entity characterized by tubuloalveolar or
pseudopapillary structures lacking a fibrovascular core and surrounded by
clear, empty spaces
[1-6]
that mimic lymphovascular invasion but are a result of retraction artifact.
Nevertheless, invasive micropapillary carcinoma expresses marked
lymphotropism, extensive axillary lymph node involvement, and frequent local
recurrence [3,
7-9].
Knowledge of the radiologic features of this entity would be useful in
alerting breast imagers to this possible diagnosis; however, there is scant
information in the medical literature describing this topic
[9-11].
We therefore retrospectively evaluated the imaging, clinical, and
histopathologic findings of invasive micropapillary carcinoma in patients who
underwent mammography, sonography, and MRI of the breast.
Materials and Methods
Study Population
A surgical pathology database at a single institution was searched to
identify the cases of patients who received a diagnosis of invasive
micropapillary carcinoma from January 1999 to December 2007 and who had
undergone preoperative imaging with mammography, sonography, or MRI. Of 80
patients with invasive micropapillary carcinoma referred to this institution,
28 had images available for review, and a total of 29 tumors were identified.
A waiver of informed consent was obtained, and the institutional review board
approved this HIPAA-compliant study.
Mammography
Standard two-view mammography was performed with one of two units (Lorad
M3, Hologic; DMR, GE Healthcare). Additional views were acquired as deemed
necessary. The mammographically detected lesions were reviewed according to
the American College of Radiology BI-RADS mammography lexicon
[12], which describes the
presence and location of masses; the presence, morphologic characteristics,
and distribution of calcifications; the shape, margin, and density of masses;
and associated findings, such as skin, nipple, or pectoralis muscle
involvement and associated axillary adenopathy.
Sonography
Real-time gray-scale and color Doppler sonography was performed with an
Elegra unit (Siemens Healthcare) with a 13- to 5-MHz linear array transducer
or an ATL Ultramark 9 unit (Philips Healthcare) with a 10- to 5-MHz linear
array transducer. The gray-scale parameters assessed included presence and
type of lesion (solid, complex cystic, or architectural distortion) and the
shape, margin features, posterior acoustic phenomena, echogenicity,
vascularity, and surrounding tissue features of the lesion (e.g., skin,
nipple, or pectoralis muscle involvement and ductal extension). Lesions were
classified according to the BI-RADS ultrasound lexicon
[13]. In addition, the
sonographic status of regional nodal basins, including the axillary, internal
mammary, and supraclavicular regions, was included, according to previously
published criteria [14,
15].

View larger version (172K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A —34-year-old woman with swelling of left breast. Final
pathologic result was invasive micropapillary carcinoma and associated ductal
carcinoma in situ, micropapillary and cribriform types associated with
calcifications. Lateromedial magnification mammogram of left breast shows
heterogeneous calcifications (arrows). White circle is nipple
marker.
|
|

View larger version (58K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B —34-year-old woman with swelling of left breast. Final
pathologic result was invasive micropapillary carcinoma and associated ductal
carcinoma in situ, micropapillary and cribriform types associated with
calcifications. Extended-field-of-view sonogram shows multiple solid
hypoechoic masses (arrowheads) in superior aspect of left breast.
|
|
MRI
MRI was performed with a 1.5-T whole-body imaging system (Signa Excite, GE
Healthcare) and a dedicated four-channel breast coil. The patient was prone,
and images were acquired in the axial and sagittal planes with the following
sequences: unenhanced axial T1-weighted spin echo (TR/TE, 500/12); sagittal
T2-weighted fat-suppressed fast spin echo (6,000/85); dynamic
contrast-enhanced sagittal T1-weighted 3D fat-suppressed fast-spoiled gradient
echo (18/4; flip angle, 15o; bandwidth, 50 kHz) at 2-minute
intervals once before and three times after patients were given an IV bolus
injection of gadopentetate dimeglumine (0.2 mmol/kg body weight, Magnevist,
Bayer Schering Pharma) at 3 mL/s with an injector; and delayed
contrast-enhanced axial T1-weighted 3D fat-suppressed fast-spoiled gradient
echo. The field of view was 160-220 mm, and the matrix size was 256 x
256 pixels. The presence or absence of areas of abnormal enhancement was
classified according to the BI-RADS MRI lexicon
[16] by the same two
mammographers who interpreted the mammograms and sonograms. Areas of abnormal
enhancement were described as masslike or nonmasslike, and enhancement
kinetics, including initial and delayed phase patterns, were noted. Associated
findings, such as skin thickening, lymphadenopathy, and chest wall invasion,
also were noted. MR images were available for review for only five of the 29
tumors.
Histopathologic Assessment
A text search for "invasive micropapillary" was performed on
the institution's surgical pathology database. All pathology reports retrieved
were re viewed by a breast pathologist with 9 years' experience. The
pathologic specimens reviewed included total mastectomy, segmental mastectomy,
and core biopsy specimens. Cases with only invasive micropapillary features or
only component of invasive micropapillary carcinoma were excluded. In all
cases in the database, at least representative histologic sections of tumor
were reviewed at our institution, where breast pathologists have reviewed all
cases of breast cancer since 1999. Information retrieved from the pathology
reports, medical records, or both included the presence of associated ductal
carcinoma in situ (DCIS), lymphovascular invasion, axillary lymph node status,
and hormone receptor and HER2 status.
Results
Clinical Findings
The study sample included 28 patients: 27 women and one man. One woman had
bilateral invasive micropapillary carcinoma, so a total of 29 tumors were
evaluated. The median patient age was 56 years (range, 28-76 years). The
initial manifestation was a palpable mass in 17 of the 28 patients (61%) and a
screening mammographic abnormality in the other 11 (39%). Associated skin
retraction was found in one of the 17 patients with palpable masses (6%),
nipple retraction in one (6%), and erythema in three (18%). The left breast
was involved in 20 of the 28 patients (71%), the right breast in seven (25%),
and both breasts in one (3%).
Imaging Findings
Mammography—All patients underwent mammography. A mass with
microcalcifications was visible in the cases of 13 of the 29 tumors (45%)
(Figs. 1A, and
1B), a mass only in seven (24%)
(Figs. 2A,
2B, and
2C), microcalcifications only
in five (17%) (Figs. 3A,
3B, and
3C), focal asymmetry with
microcalcifications in one case (3%), density in one (3%), and architectural
distortion in one (3%). The tumor was mammographically occult in one patient
(3%). These findings are presented in Table
1. Table 2 shows
the tumor size measurements obtained with mammography, sonography, and MRI. Of
the 20 masses detected with mammography, 13 (65%) were localized in the outer
upper quadrant. The predominant features were irregular shape of 16 of 20
tumors (80%), spiculated margins of 11 (55%), and high density of 17
(85%).

View larger version (182K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A —71-year-old woman with asymptomatic screening-detected
abnormality. Final pathologic result was invasive micropapillary carcinoma.
Craniocaudal spot compression mammogram of left breast shows regular
high-density mass with spiculated margins (arrow).
|
|

View larger version (183K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B —71-year-old woman with asymptomatic screening-detected
abnormality. Final pathologic result was invasive micropapillary carcinoma.
Gray-scale longitudinal sonogram of left breast shows irregular solid
hypoechoic mass with angular margins (arrows).
|
|

View larger version (199K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C —71-year-old woman with asymptomatic screening-detected
abnormality. Final pathologic result was invasive micropapillary carcinoma.
Photomicrograph shows typical histomorphologic findings of invasive
micropapillary carcinoma. Micropapillary clusters of tumor cells surrounded by
spaces represent retraction artifact (arrow).
|
|

View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A —38-year-old woman with palpable mass in left breast. Final
pathologic result was invasive micropapillary carcinoma with associated ductal
carcinoma in situ. Lateromedial magnification mammogram of left breast shows
segmental fine linear branching (white arrow) and grouped coarse
heterogeneous calcifications (black arrows).
|
|

View larger version (155K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B —38-year-old woman with palpable mass in left breast. Final
pathologic result was invasive micropapillary carcinoma with associated ductal
carcinoma in situ. Transverse gray-scale sonogram shows multiple solid
irregular hypoechoic masses (arrows) with indistinct margins.
|
|

View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3C —38-year-old woman with palpable mass in left breast. Final
pathologic result was invasive micropapillary carcinoma with associated ductal
carcinoma in situ. Longitudinal gray-scale sonogram of left axilla shows solid
oval hypoechoic lymph node (arrows) without echogenic hilus. Result
of ultrasound-guided fine-needle aspiration biopsy was metastatic
carcinoma.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2 : Tumor Size Measurements of Invasive Micropapillary Carcinomas at
Mammography, Sonography, and MRI (n = 29)
|
|
Microcalcifications were present in a total of 19 tumors. The most common
morphologic feature was pleomorphism (11 of 19 tumors, 57%), and the most
common distribution was clustered or grouped (12 of 19 tumors, 63%). Of the
five patients in whom microcalcifications were the only finding, sonography
showed no evidence of invasive micropapillary carcinoma in three patients and
multiple masses in one patient. The fifth patient did not undergo
sonography.
Sonography—Sonography was performed on 27 tumors. A mass was
visible in 23 (85%) cases (Figs.
1A,
1B,
2A,
2B,
2C,
3A,
3B,
3C,
4A, and
4B) and architectural
distortion in one (4%) case. Sonography did not depict invasive micropapillary
carcinoma in three cases (11%). The sonographic features of masses are
presented in Table 1.
Sonography also helped to determine the extent of disease. Of the 23 masses,
eight (35%) were multifocal, and one (4%) was multicentric.

View larger version (52K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A —61-year-old woman with palpable left breast mass. Final
pathologic result was invasive micropapillary carcinoma. Mammogram (not shown)
depicted heterogeneously dense breast without suspicious findings. Sagittal
dynamic contrast-enhanced T1-weighted subtraction MR image of left breast
shows multiple areas of clumped ductal enhancement (arrows) with
multicentric involvement.
|
|

View larger version (19K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B —61-year-old woman with palpable left breast mass. Final
pathologic result was invasive micropapillary carcinoma. Mammogram (not shown)
depicted heterogeneously dense breast without suspicious findings. Kinetic
analysis of A shows rapid initial enhancement and plateau curve.
|
|
Suspicious axillary lymphadenopathy was identified with sonography in 14 of
the 29 tumors (48%). The sensitivity, specificity, positive predictive value,
negative predictive value, and accuracy of axillary nodal sonography in the
detection of metastasis were 72%, 91%, 93%, 67%, and 79%. Suspicious
supraclavicular nodal disease was found in three of the 28 patients (11%), and
infraclavicular and internal mammary disease was found in one patient each
(4%). Two of the three supraclavicular lymph nodes detected were found to be
positive for metastasis at fineneedle aspiration biopsy.
MRI—MRI was performed on four patients (five tumors, one
patient having bilateral breast cancer) who had equivocal findings at
mammography and sonography. Four enhancing masses were present in three
patients, and nonmasslike enhancement was found in two patients (Figs.
4A, and
4B). The most common features
of masses were irregular shape and spiculated margins (Figs.
5A,
5B, and
5C). One of the tumors with
nonmasslike enhancement had diffuse clumped enhancement (Figs.
4A, and
4B) and the other had diffuse
stippled enhancement. The kinetics of all lesions suggested the presence of
malignancy with a rapid initial increase and washout or plateau on dynamic
contrast-enhanced studies (Figs.
4A,
4B,
5A,
5B, and
5C).

View larger version (78K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A —58-year-old woman with palpable mass in lower inner quadrant
of left breast. Final pathologic result was invasive micropapillary carcinoma.
Mammogram (not shown) depicted heterogeneously dense breast without suspicious
findings. Axial contrast-enhanced T1-weighted fat-suppressed MR image of left
breast shows palpable irregular enhancing mass (short arrow) with
spiculated margins in posterior aspect of breast and second enhancing mass
(long arrow) in subareolar position.
|
|

View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B —58-year-old woman with palpable mass in lower inner quadrant
of left breast. Final pathologic result was invasive micropapillary carcinoma.
Mammogram (not shown) depicted heterogeneously dense breast without suspicious
findings. Sagittal dynamic contrast-enhanced T1-weighted subtraction MR image
of right breast shows small enhancing mass (arrow, B) with
rapid initial enhancement and washout kinetics (C).
|
|

View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5C —58-year-old woman with palpable mass in lower inner quadrant
of left breast. Final pathologic result was invasive micropapillary carcinoma.
Mammogram (not shown) depicted heterogeneously dense breast without suspicious
findings. Sagittal dynamic contrast-enhanced T1-weighted subtraction MR image
of right breast shows small enhancing mass (arrow, B) with
rapid initial enhancement and washout kinetics (C).
|
|
In one patient, the MRI findings confirmed the presence of ipsilateral
multifocal cancer and mammographically and sonographically occult
contralateral cancer (Fig.
5B). In both breasts, the masses were spiculated and had washout
contrast kinetics highly suggestive of malignancy
(Fig. 5C). The second patient
had an irregular mass with peripheral enhancement and rapid washout kinetics.
Associated diffuse ductal enhancement was present, likely representing the
presence of accompanying DCIS. The third patient had undergone sonography that
depicted a hypoechoic mass and associated heterogeneity of breast tissue,
raising suspicion of multifocality. MRI showed multiple areas of nonmasslike
ductal enhancement with clumped distribution and highly suspicious kinetics in
two quadrants, confirming the presence of multicentric disease. The fourth
patient had a spiculated mass with heterogeneous enhancement.
Treatment and Histologic Findings
All 28 patients underwent surgery. Modified radical mastectomy was
performed on 20 patients (one patient underwent bilateral mastectomy for
bilateral cancer), and eight patients underwent breast conservation surgery.
Of the 29 tumor specimens, 15 were obtained at total mastectomy, seven at
segmental mastectomy, and seven at core needle biopsy. Lymphovascular invasion
was found in 16 of 29 (55%) tumors, and 11 of the 16 (69%) had lymph node
metastasis. Ten tumors were subjected to sentinel lymph node biopsy, 14 to
axillary nodal dissection, and five to both sentinel lymph node biopsy and
axillary nodal dissection. Axillary nodal metastasis was identified in the
cases of 18 of 29 (62%) tumors.
An intraductal component was found in 26 of the 28 patients (93%). These
tumors were usually of mixed histologic type with cribriform, solid, and
micropapillary patterns. Immunohistochemical studies showed estrogen receptor
expression in 23 patients (82%), progesterone receptor in 17 (61%), and
HER2 overexpression in 12 patients (43%).
Discussion
Invasive micropapillary carcinoma is an uncommon tumor that has more
aggressive clinical behavior than invasive ductal carcinoma, not otherwise
specified, with a high degree of lymph node involvement
[1-7].
This entity has only recently been characterized as distinct from carcinomas
with micropapillary features
[1-7].
The most common clinical manifestation of invasive micropapillary carcinoma in
our study was a palpable mass (17 of 28 patients, 61%); however, in a large
number of patients (11 of 28, 39%) the masses were detected at screening
mammography. The most common clinical finding in a study by Günhan-Bilgen
et al. [11] was a palpable
mass (94% of tumors). The left breast was affected more frequently in our
study (19 of 28 patients, 68%) than was the right breast. This finding is
similar to results presented by Kim et al.
[8], who found the left breast
affected in 60% of patients (23 of 38).
Invasive micropapillary carcinoma is characterized on H and E-stained
slides by small clusters of tumor cells with inverse polarity, surrounding
clear spaces resembling lymphovascular channels, and a high nuclear grade. The
aggressiveness of invasive micropapillary carcinoma is presumed to be related
to lymphotropism and the inverse polarity of the tumor cell clusters
[2]. In most cases, massive
axillary lymph node metastasis is present at diagnosis
[7-9].
Sonography depicted 72% of lesions of metastatic axillary lymphadenopathy in
our study and can therefore play an important role in identification and
confirmation of the presence of metastatic lymph node disease. Lymphatic
vessel invasion is an independent adverse prognostic factor and a marker of
lymph node metastasis
[7-9].
Zekioglu et al. [9] found
lymphatic vessel invasion in 75% of cases, in 82% of which lymph node
metastasis was present. In our series, lymphatic vessel invasion was found in
55% of the tumors. Of these, 69% also had lymph node metastasis. Axillary
lymph node dissection was performed for 66% (19/29) of the tumors. Nodal
positivity was present in 62%. This finding is concordant with those of
Zekioglu et al., who reported a 69% incidence of positive lymph nodes.
Invasive micropapillary carcinoma has some pathologic features different
from those of typical invasive carcinoma. It has a poor prognosis, such as a
high incidence of estrogen (82%) and progesterone (60%) receptor positivity in
our study. This finding is similar to the results of Walsh and Bleiweiss
[7], who found high rates of
positivity for estrogen and progesterone receptors (90% and 70%,
respectively). Hormone receptor positivity is typically found in
better-differentiated tumors, which have a better prognosis. We also found a
high percentage of ERRB2 (formerly HER2 or
HER2/neu) overexpression (43%), which is similar to the finding by
Walsh and Bleiweiss, who reported ERRB2 positivity in 60% of cases.
We found that most cases of associated DCIS had a mixture of cribriform,
solid, and micropapillary patterns. In the study by Walsh and Bleiweiss, the
most frequent intraductal component was micropapillary.
The imaging characteristics of invasive micropapillary carcinoma are highly
suggestive of malignancy. These tumors typically appear as a high-density
irregular mass with spiculated margins that is often associated with
microcalcifications. These findings are comparable with those of
Günhan-Bilgen et al.
[11]. Microcalcifications with
and without an associated mass or focal asymmetry were found in 66% of the
tumors in our study, in contrast to 43% in the study by Günhan-Bilgen et
al. These microcalcifications were likely representative of an associated DCIS
component. The most common sonographic feature in our study was an irregularly
shaped solid hypoechoic mass with indistinct margins, concordant with the
findings reported by Günhan-Bilgen et al. Posterior acoustic shadowing or
enhancement and hypervascularity were not distinctive findings of this
tumor.
To our knowledge, only one case report
[10] has described the MRI
findings of invasive micropapillary carcinoma as a homogeneously hypointense
mass on T1-weighted images and a heterogeneously hyperintense mass on
T2-weighted images. The margins were irregular and enhancement was patchy.
Those authors did not describe the enhancement kinetics. Although our number
of cases was small, we consider MRI an important diagnostic tool for this
variant of breast cancer, specifically for defining disease extent and
multifocality in all four patients. In one case, MRI depicted a tumor in the
contralateral breast that was mammographically occult. This finding supported
a change in staging and subsequent management.
A limitation of this study was the small sample size, which reflects the
rarity of this uncommon but aggressive tumor. A second limitation was the
retrospective nature of the study, in which not all patients underwent imaging
of the tumors with all three techniques. Many of the tumors, however, were
diagnosed during a period in which MRI was not a widely used preoperative
imaging tool.
The imaging characteristics of invasive micropapillary carcinoma are highly
suggestive of malignancy. Mammography typically shows a high-density irregular
mass with spiculated margins that is often associated with
microcalcifications. The sonographic appearance is frequently a solid
hypoechoic mass that is irregular in shape with indistinct margins without
posterior acoustic enhancement or shadowing. Invasive micropapillary carcinoma
has a high incidence of regional lymph node involvement. Therefore, a
meticulous sonographic study should aid in assessment for nodal involvement,
which necessitates aggressive management. MRI is a useful preoperative tool
for defining tumor extent and excluding multifocality, the presence of which
influences surgical planning.
References
- Fisher ER, Palekar AS, Redmond C, et al. Pathology findings from
the national surgical adjuvant breast project (protocol no. 4). Am
J Clin Pathol 1980; 73:313
-320[Medline]
- Petersen JL. Breast carcinomas with an unexpected inside-out growth
pattern: rotation of polarization associated with angioinvasion. (abstr)
Pathol Res Pract 1993;189
: 780
- Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of
the breast. Mod Pathol 1993;6
: 660-662[Medline]
- Luna-More S, Gonzalez B, Acedo C, Rodrigo I, Luna C. Invasive
micropapillary carcinoma of the breast: a new special type of invasive mammary
carcinoma. Pathol Res Pract 1994;190
: 668-674[Medline]
- Paterakos M, Watkin WG, Edgerton SM, Moore DH 2nd, Thor AD.
Invasive micropapillary carcinoma of the breast: a prognostic study.
Hum Pathol 1999;30
: 1459-1463[CrossRef][Medline]
- Pettinato G, Manivel C, Panico L, Sparano L, Petrella G. Invasive
micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of
a poorly recognized variant with a highly aggressive behavior. Am J
Clin Pathol 2004; 121:857
-866[Abstract/Free Full Text]
- Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the
breast: eighty cases of an under-recognized entity. Hum
Pathol 2001; 32:583
-589[CrossRef][Medline]
- Kim MJ, Gong G, Joo HJ, Ahn SH, Ro JY. Immunohistochemical and
clinicopathologic characteristics of invasive ductal carcinoma of breast with
micropapillary carcinoma component. Arch Pathol Lab
Med 2005; 129:1277
-1282[Medline]
- Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N. Invasive
micropapillary carcinoma of the breast: high incidence of lymph node
metastasis with extranodal extension and its immunohistochemical profile
compared with invasive ductal carcinoma.
Histopathology 2004;44
: 18-23[CrossRef][Medline]
- Wong SI, Cheung H, Tse GM. Fine needle aspiration cytology of
invasive micropapillary carcinoma of the breast: a case report.
Acta Cytol 2000;44
: 1085-1089[Medline]
- Günhan-Bilgen I, Zekioglu O, Ustün EE, Memis A, Erhan Y.
Invasive micropapillary carcinoma of the breast: clinical, mammographic, and
sonographic findings with histopathologic correlation.
AJR 2002; 179:927
-931[Abstract/Free Full Text]
- American College of Radiology. Mammography. In: Breast
imaging reporting and data system (BI-RADS), 4th ed. Reston, VA:
American College of Radiology, 2003
- American College of Radiology. Ultrasound. In: Breast
imaging reporting and data system (BI-RADS), 4th ed. Reston, VA:
American College of Radiology, 2003
- Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C. High
resolution sonographic detection of axillary lymph node metastases in breast
cancer. J Ultrasound Med 1996;15
: 241-246[Abstract]
- Vlastos G, Fornage BD, Mirza NQ, et al. The correlation of axillary
ultrasonography with histologic breast cancer downstaging after induction
chemotherapy. Am J Surg 2000;179
: 446-452[CrossRef][Medline]
- American College of Radiology. MRI. In: Breast imaging
reporting and data system (BI-RADS), 4th ed. Reston, VA: American
College of Radiology, 2003

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?